Diagnostic value of clusterin immunostaining in hepatocellular carcinoma.
Yuan LiFangfang LiuWendi ZhouSharon ZhangPeiguo ChuFan LinHanlin L WangPublished in: Diagnostic pathology (2020)
CLU is superior to pCEA and CD10 as a diagnostic immunomarker in that it can help distinguish well to moderately differentiated HCC not only from non-HCC malignancies but also from benign hepatocellular mass lesions.
Keyphrases